| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.25 | 3e-05 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | 0.2 | 0.3 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.1 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | 0.17 | 0.4 |
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | 0.16 | 0.4 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.02 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | 0.16 | 0.3 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.03 |